These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20161834)

  • 1. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening.
    Niles AL; Moravec RA; Riss TL
    Curr Chem Genomics; 2009 Jun; 3():33-41. PubMed ID: 20161834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on in vitro cytotoxicity assays for drug development.
    Niles AL; Moravec RA; Riss TL
    Expert Opin Drug Discov; 2008 Jun; 3(6):655-69. PubMed ID: 23506147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
    Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
    SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of In Vitro Metabolism Activation in High-Throughput Screening.
    Ooka M; Lynch C; Xia M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological advances in high-throughput screening.
    Liu B; Li S; Hu J
    Am J Pharmacogenomics; 2004; 4(4):263-76. PubMed ID: 15287820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of selecting protein kinase assays for lead discovery optimization.
    Ma H; Deacon S; Horiuchi K
    Expert Opin Drug Discov; 2008 Jun; 3(6):607-621. PubMed ID: 19662101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput toxicity screening and intracellular detection of nanomaterials.
    Collins AR; Annangi B; Rubio L; Marcos R; Dorn M; Merker C; Estrela-Lopis I; Cimpan MR; Ibrahim M; Cimpan E; Ostermann M; Sauter A; Yamani NE; Shaposhnikov S; Chevillard S; Paget V; Grall R; Delic J; de-Cerio FG; Suarez-Merino B; Fessard V; Hogeveen KN; Fjellsbø LM; Pran ER; Brzicova T; Topinka J; Silva MJ; Leite PE; Ribeiro AR; Granjeiro JM; Grafström R; Prina-Mello A; Dusinska M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27273980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery.
    Simon RP; Häbe TT; Ries R; Winter M; Wang Y; Fernández-Montalván A; Bischoff D; Runge F; Reindl W; Luippold AH; Büttner FH
    SLAS Discov; 2021 Sep; 26(8):961-973. PubMed ID: 34308708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probe molecule (PrM) approach in adverse outcome pathway (AOP) based high-throughput screening (HTS): in vivo discovery for developing in vitro target methods.
    Angrish MM; Madden MC; Pleil JD
    Chem Res Toxicol; 2015 Apr; 28(4):551-9. PubMed ID: 25692543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds.
    Witt G; Keminer O; Leu J; Tandon R; Meiser I; Willing A; Winschel I; Abt JC; Brändl B; Sébastien I; Friese MA; Müller FJ; Neubauer JC; Claussen C; Zimmermann H; Gribbon P; Pless O
    Cell Biol Toxicol; 2021 Apr; 37(2):229-243. PubMed ID: 32564278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
    Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
    J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence polarization assays in high-throughput screening and drug discovery: a review.
    Hall MD; Yasgar A; Peryea T; Braisted JC; Jadhav A; Simeonov A; Coussens NP
    Methods Appl Fluoresc; 2016 Apr; 4(2):022001. PubMed ID: 28809163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of impermeant, DNA-binding dye fluorescence as a real-time readout of eukaryotic cell toxicity in a high throughput screening format.
    Chiaraviglio L; Kirby JE
    Assay Drug Dev Technol; 2014 May; 12(4):219-28. PubMed ID: 24831788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty-Quantified Hybrid Machine Learning/Density Functional Theory High Throughput Screening Method for Crystals.
    Noh J; Gu GH; Kim S; Jung Y
    J Chem Inf Model; 2020 Apr; 60(4):1996-2003. PubMed ID: 32208718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery.
    Chiu W; Schepers J; Francken T; Vangeel L; Abbasi K; Jochmans D; De Jonghe S; Thibaut HJ; Thiel V; Neyts J; Laporte M; Leyssen P
    Antiviral Res; 2023 Feb; 210():105506. PubMed ID: 36565756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High Throughput.
    Simon RP; Winter M; Kleiner C; Wehrle L; Karnath M; Ries R; Zeeb M; Schnapp G; Fiegen D; Häbe TT; Runge F; Bretschneider T; Luippold AH; Bischoff D; Reindl W; Büttner FH
    SLAS Discov; 2021 Jan; 26(1):44-57. PubMed ID: 33073664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid and affordable screening platform for membrane protein trafficking.
    Snyder JC; Pack TF; Rochelle LK; Chakraborty SK; Zhang M; Eaton AW; Bai Y; Ernst LA; Barak LS; Waggoner AS; Caron MG
    BMC Biol; 2015 Dec; 13():107. PubMed ID: 26678094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate.
    Marks BD; Smith RW; Braun HA; Goossens TA; Christenson M; Ozers MS; Lebakken CS; Trubetskoy OV
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):73-81. PubMed ID: 15090158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.